Related websites>
-
NMPA issues notice on publicity and implementation of Vaccine Administration Law
The National Medical Products Administration (NMPA) released a notice on the Vaccine Administration Law of the People's Republic of China on July 25.
-
Tell China's drug regulatory stories to the world
The National Medical Products Administration (NMPA) of the People's Republic of China launched its official English-language website on July 18, a move to disseminate the agency's drug regulatory information and related online public resources after its establishment.
-
2019 China Cancer Immunotherapy Workshop Successfully Held
2019 China Cancer Immunotherapy Workshop was successfully held on June 29- 30, 2019 in Tianjin, China.
- NMPA Issued the Announcement on Issues Pertaining to the Implementation of Drug Standards in the Consistency Evaluation of the Quality and Efficacy of Generic Drugs
- NMPA Issued the Notice on Expanding the Pilot of the Medical Device Registrant System
- NMPA Issued the Announcement on Cancellation of 16 Certification Items (Second Batch)
- NMPA Promulgated the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor VIII and the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor IX
- NMPA Promulgated the Guidelines for Clinical Safety Literature Evaluation of Marketed Drugs (Interim)
- General Office of the State Council Issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019
